Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Moll

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Frontiers in Medicine|November 12, 2021
RESTORE Survey on the Public Perception of Advanced Therapies and ATMPs in Europe-Why the European Union Should Invest More!Gady Goldsobel, Christoph von Herrath, Stephan Schlickeiser, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 12, 2017
Tumour necrosis factor-alpha in uraemic serum promotes osteoblastic transition and calcification of vascular smooth muscle cells via extracellular signal-regulated kinases and activator protein 1/c-FOS-mediated induction of interleukin 6 expressionDaniel Zickler, Christian Luecht, Kevin Willy, et al.
Journal of Clinical Medicine|March 29, 2023
Nailfold Videocapillaroscopy for Non-Invasive Assessment of Microcirculation and Prognostic Correlation with Endothelial Dysfunction, Cardiovascular Risk Factors, and Non-HLA Antibodies in Heart Transplant Recipients: A Pilot StudyDorota Sikorska, Dorota Kamińska, Rusan Catar, et al.
Stem Cells Translational Medicine|July 15, 2016
Type 1 Diabetes Mellitus Donor Mesenchymal Stromal Cells Exhibit Comparable Potency to Healthy Controls In VitroLindsay C Davies, Jessica J Alm, Nina Heldring, et al.
Frontiers in Immunology|October 5, 2023
Expanded Hemodialysis ameliorates uremia-induced impairment of vasculoprotective KLF2 and concomitant proinflammatory priming of endothelial cells through an ERK/AP1/cFOS-dependent mechanismHongfan Zhao, Dashan Wu, Michael Adu Gyamfi, et al.
Frontiers in Immunology|February 21, 2022
Angiogenic Role of Mesothelium-Derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in Patients Receiving Peritoneal Dialysis as Renal Replacement TherapyRusan Ali Catar, Maria Bartosova, Edyta Kawka, et al.
Plos One|January 24, 2014
Do ABO blood group antigens hamper the therapeutic efficacy of mesenchymal stromal cells?Guido Moll, Annika Hult, Lena von Bahr, et al.
Frontiers in Immunology|December 3, 2021
Expanded Hemodialysis Therapy Ameliorates Uremia-Induced Systemic Microinflammation and Endothelial Dysfunction by Modulating VEGF, TNF-α and AP-1 SignalingRusan Catar, Guido Moll, Julian Kamhieh-Milz, et al.
Clinical Immunology (Orlando, Fla.)|February 16, 2025
Stimulation of endothelin-1 production by autoantibodies present in patients with scleroderma renal crisisPinchao Wang, Dashan Wu, Zexian Gong, et al.
Stem Cells (Dayton, Ohio)|April 24, 2012
Are therapeutic human mesenchymal stromal cells compatible with human blood?Guido Moll, Ida Rasmusson-Duprez, Lena von Bahr, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Frontiers in Medicine|November 12, 2021
RESTORE Survey on the Public Perception of Advanced Therapies and ATMPs in Europe-Why the European Union Should Invest More!Gady Goldsobel, Christoph von Herrath, Stephan Schlickeiser, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 12, 2017
Tumour necrosis factor-alpha in uraemic serum promotes osteoblastic transition and calcification of vascular smooth muscle cells via extracellular signal-regulated kinases and activator protein 1/c-FOS-mediated induction of interleukin 6 expressionDaniel Zickler, Christian Luecht, Kevin Willy, et al.
Journal of Clinical Medicine|March 29, 2023
Nailfold Videocapillaroscopy for Non-Invasive Assessment of Microcirculation and Prognostic Correlation with Endothelial Dysfunction, Cardiovascular Risk Factors, and Non-HLA Antibodies in Heart Transplant Recipients: A Pilot StudyDorota Sikorska, Dorota Kamińska, Rusan Catar, et al.
Stem Cells Translational Medicine|July 15, 2016
Type 1 Diabetes Mellitus Donor Mesenchymal Stromal Cells Exhibit Comparable Potency to Healthy Controls In VitroLindsay C Davies, Jessica J Alm, Nina Heldring, et al.
Frontiers in Immunology|October 5, 2023
Expanded Hemodialysis ameliorates uremia-induced impairment of vasculoprotective KLF2 and concomitant proinflammatory priming of endothelial cells through an ERK/AP1/cFOS-dependent mechanismHongfan Zhao, Dashan Wu, Michael Adu Gyamfi, et al.
Frontiers in Immunology|February 21, 2022
Angiogenic Role of Mesothelium-Derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in Patients Receiving Peritoneal Dialysis as Renal Replacement TherapyRusan Ali Catar, Maria Bartosova, Edyta Kawka, et al.
Plos One|January 24, 2014
Do ABO blood group antigens hamper the therapeutic efficacy of mesenchymal stromal cells?Guido Moll, Annika Hult, Lena von Bahr, et al.
Frontiers in Immunology|December 3, 2021
Expanded Hemodialysis Therapy Ameliorates Uremia-Induced Systemic Microinflammation and Endothelial Dysfunction by Modulating VEGF, TNF-α and AP-1 SignalingRusan Catar, Guido Moll, Julian Kamhieh-Milz, et al.
Clinical Immunology (Orlando, Fla.)|February 16, 2025
Stimulation of endothelin-1 production by autoantibodies present in patients with scleroderma renal crisisPinchao Wang, Dashan Wu, Zexian Gong, et al.
Stem Cells (Dayton, Ohio)|April 24, 2012
Are therapeutic human mesenchymal stromal cells compatible with human blood?Guido Moll, Ida Rasmusson-Duprez, Lena von Bahr, et al.
Pageof 6